Track the virus blogspot

For instance, the genomic data allowed the researchers to identify previously unsuspected links between certain cases of COVID It also helped to confirm other links that were otherwise unclear.

Nevertheless, the findings demonstrate the value of genomic data for tracking the virus and pinpointing exactly where in the community it is spreading. This can help to fill in important gaps in the community-based data that contact tracers often use. Even more exciting, by combining traditional contact tracing, genomic surveillance, and mathematical modeling with other emerging tools at our disposal, it may be possible to get a clearer picture of the movement of SARS-CoV-2 and put more targeted public health measures in place to slow and eventually stop its deadly spread.

Nat Med. Vitali Sintchenko University of Sydney, Australia. Posted In: News. Has anyone tried to trace the path of these infections? The process that is being used to remove the path of the virus is not working. Are all deliveries of supplies to these facilities inspected for the virus contamination? It can be on the delivered food supplies, mail, any other other delivered supplies, or brought in by anyone. I do not think just taking a temperature alone will detect the presence of the virus.

The unbroken chain of the spreading virus continues to elude us. Looking forward to the next New Year celebration, and people traveling to the celebration, just about 6months away, how will that be controlled? Are studies being replicated about viral viability on different surfaces?

How much and what do we need to clean regarding food packaging? If it is so contagious then why have we not been given or instructed what to do with used masks? This would be the biggest bio-hazard ever if it were true. Will it be possible to positively identify who infected you by using some genomic or other scientific info information carried by the covid virus? Skip to content As the Omicron variant begins to drive case counts higher in Oregon, many more people need guidance and resources to ensure they and those around them stay safe.

What do I do if I test positive? Have questions or need help? Call to speak with a public health professional. New tool to help track the virus Before the Omicron surge, local public health LPHA professionals around the state called COVID-positive individuals to gather detailed information and help connect them to resources.

Why should you take the survey? Faria and E. Sabino et al. Science : Variant Proportions. Centers for Disease Control and Prevention.

Samir Bhatt Imperial College. Posted In: News. Tags: ACE2 , B. I do not mean to disrespect or assume anything about any part of medicine but some serious questions come to my mind: 1. Since apparently, recognition of a serious new threat came about in November, I have to wonder why some vaccines were not sent to Manaus by some time in December — to do a study, admittedly with far fewer participants than normal and under adverse conditions, but to see as best I can if our vaccines worked on that variant before a massive vaccination program which, had we been unlucky, would have not prevented a P1 surge which could have been taking place right now.

The data on the Pfizer vaccine is certainly reassuring, but even now, actual field data would be nice. To be honest, that goes over my head, but the politicized disputes about continued use of masks seems to indicate our authorities do not feel certain our vaccines stop all the variants. Fauci sort of admitted that after being forced to. I respect Dr. Fauci but I think he should be saying this rather definitively, without being pushed.

And I know, as the bearer of possible bad news, he will get castigated by ignorant and immature people for it, but the rest of us need to know. I am upset, if the variant was identified so far back, and certainly they knew something bad was going on by late November, that we were not told to avoid travel to Brazil.

Fauci was a prominent public figure by that point, I believe he should have told people unambiguously, travel to Brazil was too risky. IF that had been done, perhaps we would have fewer cases of P1 in the US now — maybe it will not matter, but before the encouraging data from Pfizer, this should have been done as a precaution IMO. If this was remiss, it appears to be an omission other countries are also guilty of, but perhaps no one is being adequately proactive?

I am concerned that we did not send vaccines to Manaus to test if our vaccines — not yet even having EUA but it was certainly contemplated — would be effective against the variant, before we started a massive vaccination campaign which might have had limited effectiveness. It seems like a very big oversight.

It would be interesting if Dr. Collins could update us on the progress hopefully being made by the drug manufacturing companies on researching and developing a third dose that can stop the 8 most-talked about variants. If you have comments or questions not related to the current discussions, please direct them to Ask NIH. You are encouraged to share your thoughts and ideas.